The Department of Health Care Finance is issuing the attached policy and procedure (P&P) to address barriers to access to buprenorphine and a lack of consistency in prior authorization (PA) and dosage requirements, both among managed care organizations (MCO) and between MCO and fee-for-service (FFS) requirements. 

 

This P&P applies to all Medicaid providers and managed care organizations. It is effective June 1, 2016.